MFUSManitoba Follow Up Study (Canada)
References in periodicals archive ?
offered a report on the nature of the rare complications from MFUS, which have included mild and fleeting ecchymosis, edema, erythema, and nerve paralysis.
While no studies have yet looked at the effects of combining the use of nutraceuticals and cosmeceuticals before or after an MFUS procedure, anecdotal reports suggest positive outcomes, to which these agents have been thought to have contributed.
For example, using the appetite question, fair/poor appetite was reported by 13.2% of the MFUS participants, which is consistent with a mixed sample of frail and well seniors (e.g., fair/poor appetite 12.6%) [11], greater when compared with healthy and younger seniors (e.g., fair/poor appetite = 8.2%) [33], and lower when compared with frail seniors who used community support services (e.g., fair/poor appetite = 27.5%) [34].
Constructs of perceived healthfulness of one's diet and the belief that diet impacts aging are unique to the MFUS sample, and thus provide a distinctive view of construct validity.
Most importantly, this secondary analysis, although large, was based on "survivors" included in the MFUS and all participants were male.
Cohort profile: the Manitoba follow-up study (MFUS).
(27) The ongoing operation of MFUS receives annual ethical approval from the University of Manitoba Health Research Ethics Board.
Over the four decades between 1968 and 2007, 437 men (11% of the 3,983 MFUS participants) were given a diagnosis of T2DM.
In fall 2007, MFUS began to include an examination of the association between successful aging and nutritional risk among study members.
In addition to SCREEN II, the MFUS Nutrition Survey included questions on the following factors:
Surveys were mailed to 690 MFUS members in December 2007.
* Willing to receive mailed surveys (provided during annual MFUS follow-up)